Lasermach gets FDA nod

Lasermach by Wingderm® Receives FDA Clearance for All Three Wavelengths

March 26, 2026
11:40 am

BEIJING, March 26, 2026 /PRNewswire/ -- Wingderm®, a manufacturer of medical aesthetic devices, announces that its Lasermach system has received expanded clearance from the U.S. Food and Drug Administration (FDA). With this latest clearance, Lasermach now achieves FDA clearance across all three wavelengths.

Compared to its previous single-wavelength configuration, Lasermach now can treat a broader range of skin tones and hair types. This increased versatility enables MedSpas to satisfy a wide range of hair removal demands using a single platform, simplifying device selection and daily operations.

Wingderm® will showcase Lasermach at the upcoming AAD Annual Meeting, taking place March 27–29 in Denver, Colorado. We welcome dermatology professionals and industry partners to visit Booth 4342 to learn more about the system and exchange ideas.

Lasermach by Wingderm® Receives FDA Clearance for All Three Wavelengths

Sign up for Blog Updates